Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Biogen Bet on Alzheimer’s Drug Faces Poor Odds, Says UBS
2 How Nonprofit Foundations Can Sustainably Fund Disease Research
3 Edited Transcript of MRK.N earnings conference call or presentation 27-Oct-20 12:00pm GMT
4 To improve medication use among older adults, UB's Team Alice partners with US Deprescribing Research Network
5 Frontier Biotechnologies Inc.'s IPO debut on SSE STAR Market today
6 Ixico secures two Huntington's disease clinical trial contracts
7 Annovis Bio CEO Receives 2020 Smart Business Dealmaker Award
8 Vaccitech expands management team with hires including CMO and CFO
9 UBS Q3 Profit Nearly Doubles, Proposes Dividend; Stock Up
10 Elective surgeries seen driving Q3 medtech comeback, but can it last?
11 Laboratory Corp Of America Holdings (LH) Q3 2020 Earnings Call Transcript
12 PRA Health Sciences (PRAH) Set to Announce Earnings on Wednesday
13 Pfizer's Covid-19 vaccine doesn't add a 'tremendous amount' to the company's valuation: Analyst
14 Knoxville Biz Ticker: Keep Knoxville Beautiful to host virtual Summit
15 Mirati Therapeutics (NASDAQ:MRTX) Trading 6.3% Higher on Analyst Upgrade
16 Edited Transcript of RENT3.SA earnings conference call or presentation 28-Oct-20 3:00pm GMT
17 Allergy Therapeutics screens first patients in grass pollen study
18 Merck & Co. (MRK) Q3 2020 Earnings Call Transcript
19 4 Safe Stocks to Lock Down Profits
20 Stocks making the biggest moves in the premarket: Procter & Gamble, Travelers, Logitech & more
21 Surge In Commercial Payments Pushes ACH Payments Volume Up 9 Pct In 3Q
22 How much is COVID-19 affecting procedure volumes for medtech?
23 Jazz Pharma Buys FAAH Inhibitor Program Of SpringWorks Therapeutics
24 Founder of Chester County-based Drug Company Receives 2020 Smart Business Dealmaker Award
25 Does CSL's Share Price Reflect All Risks?
26 Pfizer Inc. (PFE) Q3 2020 Earnings Call Transcript
27 FTSE 100 mirrors yesterday"s steady decline; Wall Street muddled over coronavirus fears
28 Christopher G. Mccann Sells 17,850 Shares of 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) Stock
29 Cantor Fitzgerald Raises Aptinyx (NASDAQ:APTX) Price Target to $12.00
30 Edwards Lifesciences Corp (EW) Q3 2020 Earnings Call Transcript
31 These 2 Big Earnings Reports Led Stock Markets Lower Tuesday
32 Mylan (NASDAQ:MYL) PT Lowered to $16.00 at Wells Fargo & Company
33 Breakingviews
34 Short Interest in Trevena Inc (NASDAQ:TRVN) Expands By 16.9%
35 AU vs. AEM: Which Stock Should Value Investors Buy Now?
36 A P MOLLARMRSK (AMKBY) Upgraded to Buy: Here's Why
37 Amazon touts jobs record as congressional scrutiny intensifies
38 Avnet (AVT) Expected to Beat Earnings Estimates: Should You Buy?
39 Net Asset Value(s)
40 Colliers International: 3Q Earnings Snapshot
41 Icon PLC (ICLR) Q3 2020 Earnings Call Transcript
42 Advamed: Diagnostic COVID-19 tests shipments hit 200M
43 Oncorus Finalizes $87 Million U.S. IPO Effort
44 C4 Therapeutics Proposes $150 Million IPO Terms
45 Amid Volatile Markets, GenomeWeb Index Up 3 Percent in September
46 Wealth Management Market | Coronavirus (COVID-19) Impact Analysis with Business Opportunities, Survey And Growth Forecast 2020-2026
47 C4 Therapeutics Announces Pricing of an Upsized Initial Public Offering
48 Edited Transcript of DHR.N earnings conference call or presentation 22-Oct-20 12:00pm GMT
49 Woori BMO Group Comments on Bayer Spending Up To $4 Billion For Gene-Therapy Firm AskBio
50 Fantasy Football Week 8 Rankings: Who to start at FLEX
51 UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal
52 Trump could return to public engagements by Saturday, doctor says, as campaign pushes on debate
53 SELLAS to Present at UBS Virtual Global Healthcare Conference
54 Nation's wealthiest see riches skyrocket
55 AC Immune CEO to Showcase Novel Target Programs at UBS Global Healthcare Conference
56 Masimo to Present in UBS Virtual Global Healthcare Conference
57 FDA Urges Virtual Patient Visits as Coronavirus Disrupts Clinical Trials
58 Danaher Corp. (DHR) Q3 2020 Earnings Call Transcript
59 RedHill Biopharma to Present at the UBS Virtual Global Healthcare Conference
60 Applied Therapeutics to Present at the UBS Global Healthcare Conference
61 Form 6-K GENMAB A/S For: Sep 30
62 ASX ends higher; Westpac sells Zip stake
63 Arcellx to Present at the UBS Virtual Global Healthcare Conference
64 Buy Novartis Stock, Analyst Says. It Should Rise 20%.
65 Stocks Open Higher Ahead of Stimulus Talks Deadline
66 COVID-19 vaccine verdicts loom as next big market risk
67 What is remdesivir? Gilead Sciences drug reportedly shows promise treating coronavirus
68 Yahoo News/YouGov poll: Despite questions about the 'laptop from hell,' most Americans think the Trumps are more 'corrupt ' than the Bidens
69 Surface Oncology to Present at the UBS Virtual Global Healthcare Conference
70 Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress
71 WindMIL Therapeutics to Present at UBS Virtual Global Healthcare Conference
72 NVAX Begins Vaccine Trial In S.Africa, PSTX Slapped With Clinical Hold, UTHR To Face FDA In Apr.
73 Will COVID-19 change how Big Pharma does clinical trials?
74 Clinical testing and the new virtual reality in time of COVID-19
75 Another Hydroxychloroquine Trial Still Leaves Questions on Its Use Against Covid-19
76 Lennox International (NYSE:LII) Updates FY20 Earnings Guidance
77 Merck, Roche, Amgen Stocks React to Release of Cancer-Drug Data
78 Vaxart Gets FDA Sign-Off on Phase 1 Clinical Trial for Its Coronavirus Vaccine
79 Moderna Slowed Enrollment in Its Phase 3 Coronavirus Vaccine Clinical Trial
80 Merck (Finally) Starts a Clinical Trial of its Coronavirus Vaccine
81 Rx.Health taps Entra Health cofounder as new CEO, TestCard's swath of new appointments and more digital health hires
82 Biopharma Update on the Novel Coronavirus: April 1
83 Feinstein Institutes Begins Enrolling Patients In COVID-19 Clinical Trials
84 How reborn pharma giant AstraZeneca is taking the lead against COVID-19
85 The Coronavirus Pandemic Is Causing a ‘Serious Slowdown’ in Drug Trials
86 IPO Launch: C4 Therapeutics Readies $150 Million IPO Plan
87 Chi-Med Highlights Clinical Data to be Presented at the Upcoming ESMO Virtual Congress 2020
88 IPO Launch: Repare Therapeutics Proposes U.S. IPO Terms
89 Moderna, Novavax and Inovio Get Boost From AstraZeneca Coronavirus Vaccine Trial Pause
90 EQ Soars, INMB Up On Promising Alzheimer's Trial Data, ALT To Move AdCOVID Into Clinical Trial In Q4
91 Diffusion Pharmaceuticals Doses First Two Patients with TSC in COVID-19 Clinical Trial
92 Arbutus to Present at UBS Virtual Global Healthcare Conference
93 Moody's: Clinical trials troubled amid coronavirus outbreak, drug sales not so much
94 Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist
95 How a clinical management strategy can reduce pharmacy spend and improve employee health
96 Affimed Announces Two New Appointments to Its Supervisory Board
97 Veeva Announces Vault Site Connect to Automate Information Sharing in Clinical Trials
98 Maverick Therapeutics Announces Key Executive Promotion and Scientific Advisory Board Appointments to Further Prepare for Clinical Development in 2021
99 Syneos Health to Present at the UBS Virtual Global Healthcare Conference
100 Ex-AstraZeneca exec Kristen Buck hops aboard Icon as CMO; Immunocore taps Brian DiDonato as CFO